Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCYBA.L Regulatory News (CYBA)

  • There is currently no data for CYBA

Contract

29 Oct 2021 08:00

RNS Number : 7040Q
CYBA PLC
29 October 2021
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

29 October 2021

 

CYBA plc

 

New Narf R&D Contract

 

CYBA plc ("CYBA" or the "Company") is pleased to announce that its acquisition target Narf Industries LLC and Narf Industries PR LLC (together "Narf" or the "Narf Group") has won another contract (the "Contract") for the United States Department of Defense (the "DoD"). Narf has begun the R&D phase and expects the effort to result in additional cyber security software and IP in which it will have a proprietary interest.

 

Narf expects that software and techniques developed under this new contract will progress through Narf's core business model and R&D transition pipeline to join other successful efforts similar to Narf's Threat Intelligence for Grid Recovery product ("TIGR"). TIGR is a Power Grid Cyber Security Solution developed for the Defense Advanced Research Projects Agency's ("DARPA") Rapid Attack Detection, Isolation and Characterization Systems ("RADICS") program, which concluded in 2021 with a public budget of more than $139M USD. Narf is spearheading TIGR's transition to the commercial market of 55,000 electric grid substations in the US alone that require advanced cyber security defenses.

 

The Contract is in addition to the one announced by Cyba on 8 June 2021 for DARPA's Hybrid AI Exploration Social Code Program. Narf's 'Social Cyber' effort leverages AI and advanced analytics to ensure the integrity of open source software platforms which underpin large portions of the DoD, public clouds, and technology platform infrastructure. Early R&D has been promising and Narf has already begun a product roadmap and use case studies in expectation of commercialising its early R&D results.

 

A summary on Narf was included in the Company's Listing Prospectus (Page 24) which can be found at the Company's webpage, https://cybaplc.com/investor-relations/corporate-documents. Narf operates within the Threat Intelligence Sector carrying out computer security research and developing and licencing software on a SaaS basis to detect threats to computer systems. It also provides Incident Response services to assist its clients to identify and neutralise active threats. Its clients are US governmental agencies, like DARPA, and large US corporations. Narf has a number of patents for its technology, facilitating the continuous development of its products and in 2021 intends to expand both current and newly developed products and services through its active revenue channels in the US and beyond. Further information can be found on Narf's website https://narfindustries.com/.

 

Robert Mitchell, Chairman of Cyba, said: "This new contract win highlights the recent growth trajectory Narf has been on. We are pleased, but in no way surprised, that Narf are now able to show traction on all stages of the pipeline. They have onboarded new key team members in the last few months and we are really excited about completing this transaction and getting on with the full rollout."

 

 

ENDS

 

About CYBA plc

CYBA plc ("CYBA") is a special purpose acquisition company ("SPAC") seeking suitable acquisition targets in the Cyber Security sector. CYBA intends to implement its strategy focussed on building a group capable of offering Cyber and Cybersecurity solutions in the US and beyond.

 

The Company intends to leverage the deep industry knowledge of its board and associates to undertake due diligence on the commercial attributes of a target entity's business.

 

For further information on the Company please visit www.cybaplc.com, with the Company's Prospectus to be found at www.cybaplc.com/investor-relations/corporate-documents or contact:

 

Robert Mitchell

 

CYBA

Tel: +44 (0) 20 3468 2212

Peter Krens

Tennyson Securities

Tel: +44 (0)207 186 9030

 

 

Forward-looking statements

Certain statements in this announcement constitute ''forward-looking statements''. Forward-looking statements include statements concerning the plans, objectives, goals, strategies and future operations and performance of the Company and the assumptions underlying these forward-looking statements. The Company uses the words ''anticipates'', ''estimates'', ''expects'', ''believes'', ''intends'', ''plans'', ''may'', ''will'', ''should'', and any similar expressions to identify forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause the Company's actual results, performances or achievements to be materially different from any future results, performances or achievements expressed or implied by such forward-looking statements. Such forward-looking statements are based on numerous assumptions regarding present and future business strategies and the environment in which the Company will operate in the future. These forward-looking statements speak only as at the date of this announcement. The Company is not obliged, and does not intend, to update or to revise any forward-looking statements, whether as a result of new information, future events or otherwise except to the extent required by any applicable law or regulation. All subsequent written or oral forward-looking statements attributable to the Company, or persons acting on behalf of the Company, are expressly qualified in their entirety by the cautionary statements contained throughout this announcement. As a result of these risks, uncertainties and assumptions, a prospective investor should not place undue reliance on these forward-looking statements.

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CNTGLBDGUXDDGBC
Date   Source Headline
4th Aug 202212:00 pmRNSChange of Name
28th Jul 20225:00 pmRNSResult of AGM & Change of Name
25th Jul 20227:00 amRNSTIGR Contract
6th Jul 20227:00 amRNSNotice of AGM
30th Jun 20227:00 amRNSFinal Results
20th Jun 20227:00 amRNSCorporate Update
27th May 202212:00 pmRNSIssue of Equity
16th May 20227:00 amRNSIssue of Equity
4th Apr 20223:45 pmRNSHolding(s) in Company
4th Apr 20223:45 pmRNSHolding(s) in Company
4th Apr 20223:45 pmRNSHolding(s) in Company
4th Apr 20222:18 pmRNSDirector/PDMR Shareholding
1st Apr 20223:42 pmRNSHolding(s) in Company
1st Apr 20223:30 pmRNSDirector/PDMR Shareholding
1st Apr 20223:27 pmRNSDirector/PDMR Shareholding
1st Apr 20221:43 pmRNSDirector/PDMR Shareholding
16th Mar 20227:02 amRNSAgreement
15th Mar 202210:19 amRNSReadmission of Enlarged Group
14th Mar 202211:47 amRNSGM Statement
17th Feb 20228:30 amRNSNarf Acquisition and Approved Prospectus
2nd Feb 20227:00 amRNSStatement re completion of fundraise
19th Jan 202211:05 amRNSSecond Price Monitoring Extn
19th Jan 202211:00 amRNSPrice Monitoring Extension
18th Jan 20227:00 amRNSTarget company - Polyswarm NCT Price Movement
10th Dec 202111:00 amRNSPrice Monitoring Extension
29th Oct 20218:00 amRNSContract
29th Oct 20217:00 amRNSHalf-year Report
20th Oct 20217:00 amRNSRegulatory Approval
29th Jul 20217:00 amRNSAcquisition Update
22nd Jul 202112:26 pmRNSHolding(s) in Company
6th Jul 20212:37 pmRNSHolding(s) in Company
30th Jun 202110:30 amRNSAudited results - nine months to 31 December 2020
25th Jun 20219:16 amRNSHolding(s) in Company
23rd Jun 20216:04 pmRNSHolding(s) in Company
21st Jun 20214:41 pmRNSSecond Price Monitoring Extn
21st Jun 20214:36 pmRNSPrice Monitoring Extension
21st Jun 202112:43 pmRNSAcquisition
13th May 20217:17 amRNSIssue of Equity
28th Apr 20217:00 amRNSInitial Application for trading on US OTCQB
8th Mar 20217:00 amRNSAdmission to Trading & First Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.